DC4U
DC4U is a life science company that develops technologies enabling steering the human immune response. Its core expertise is the immunological application of glycobiology. Based on this knowledge a platform technology (GlycoDC) was developed which can modulate the immune system and can be applied to antigen based therapeutics and products. Its GlycoDCTM technology can either potentiate or suppress the immune system via specific targeting of dendritic cells by glycan modified antigen conjugates.
DC4U
Social Links:
Industry:
Biotechnology Life Science Medical Medical Device
Founded:
2006-01-01
Address:
Breukelen, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.dc4u-technologies.nl
Total Employee:
1+
Status:
Active
Contact:
+31 (0)346 74 5139
Email Addresses:
[email protected]
Total Funding:
71.43 K EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Google Cloud Google Cloud Netherlands
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - DC4U
Official Site Inspections
http://www.dc4u-technologies.nl
- Host name: 230.142.214.35.bc.googleusercontent.com
- IP address: 35.214.142.230
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "DC4U"
Overview - DC4U Technologies
DC4U BV (Amsterdam, the Netherlands) is a life science company founded in 2006. Our core expertise is the immunologic application of glycobiology. The company utilizes its proprietary …See details»
DC4U - Crunchbase Company Profile & Funding
Organization. DC4U . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Management - DC4U Technologies
Yvette van Kooyk is a named inventor on 4 patent applications, has (co-) authored more than 180 peer-reviewed publications in international well …See details»
DC4U Technologies Overview | SignalHire Company Profile
Organization Website: dc4u-technologies.nl : DC4U Technologies industries Biotech: Headquarters Location: De Boelelaan 1108, Amsterdam, Noord Holland, 1081 HZ NL De …See details»
DC4U Technologies - LinkedIn
DC4U is a life science company founded in 2006. Our core expertise is the immunological application of glycobiology. Based on this knowledge a platform technology (GlycoDC) was developed which can ...See details»
DC4U - Smart Health Amsterdam
DC4U is a life science company developing technologies that enable steering the human immune response. Our GlycoDCTM technology can either potentiate or suppress the immune system …See details»
DC4U 2025 Company Profile: Valuation, Funding & Investors
DC4U General Information Description. Developer of immunotherapy intended to cure allergies and autoimmune diseases. The company utilizes its proprietary technology for developing …See details»
DC4U Company Profile - Office Locations, Competitors, Revenue
DC4U has 5 employees at their 1 location and $75.64 k in total funding,. See insights on DC4U including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
DC4U - VentureRadar
DC4U BV is a spin-off company of the VU University medical center (VUmc). DC4U is a life science company developing technologies that enable steering the human immune response. …See details»
DC4U B.V. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DC4U B.V. of Abcoude, Utrecht. Get the latest business insights from Dun & Bradstreet. DC4U B.V. D&B …See details»
DC4U Technologies - Overview, News & Similar companies
DC4U Technologies contact info: Phone number: +31 346745139 Website: www.dc4u-technologies.nl What does DC4U Technologies do? DC4U Technologies is a company that …See details»
Introduction - DC4U Technologies
DC4U is a life science company developing technologies that enable steering the human immune response. Our GlycoDC TM technology can either potentiate or suppress the immune system …See details»
GlycoDCTM secures €1.4M Innovation Credit for immunotherapy …
May 23, 2023 Congratulations to DC4U, which has been awarded an innovation credit of €1.4M to further develop their GlycoDCTM platform! ... DC4U’s technology platform GlycoDCTM uses …See details»
Dc4U Technologies-Overview, Competitors & Contact Info
Get Dc4U Technologies’s (dc4u-technologies.nl) location in North Holland Netherlands, revenue, industry, competitors, technographics and contact information. Find and reach similar …See details»
DC4U - CipherBio
Explore DC4U's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
DUTCH DC4U AND LUMC CONSORTIUM RECEIVE €1.7 ... - DC4U …
For more info visit: www.dc4u-technologies.nl . About Intavis Peptide Services . IPS is a leading provider of synthetic peptides, peptide arrays, peptide pools and resins as well as a research …See details»
€1.7m Eurostars awarded to: Cure diabetes with the help of sugars!
Jul 28, 2022 The project is led by DC4U Technologies, a Dutch life science company that developed GlycoDC TM: a technology that enables steering the human immune response. …See details»
News & Updates Archives - DC4U Technologies
DC4U was recently awarded a 2,7 million euro valued Eurostars project for the development a next-generation allergy vaccine to treat grass-pollen induced allergic rhinitis and asthma. In …See details»
Research - DC4U Technologies
DC4U explores the efficacy of several glycan modified long peptide antigens, alone and in combination, and in combination with adjuvants and checkpoint inhibitors. Besides, specific …See details»